NCT06988956 2025-05-25
Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
Clinical Trials
11 trialsNCT06598917 2024-09-19
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT
China Medical University Hospital
Phase 2 Not yet recruiting
NCT06187597 2024-03-12
EC-CRT-007
Sun Yat-sen University
Phase 2 Recruiting
NCT06194734 2024-03-07
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT05636150 2022-12-05
A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03660449 2022-10-26
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT02606916 2020-09-04
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
Sun Yat-sen University
Phase 2 Completed
NCT01831531 2019-02-15
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
Fudan University
Phase 2 Completed
NCT02913066 2017-06-16
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
Mianyang Central Hospital
Phase 2 Unknown
NCT02677597 2016-02-09
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
Fudan University
Phase 3 Unknown
NCT02586753 2015-10-26
Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus
Mianyang Central Hospital
Phase 2 Unknown